Answer
Rizatriptan benzoate activates serotonin 5-HT1B/1D receptors on intracranial blood vessels and trigeminal sensory nerves, which may constrict pain-producing vessels and inhibit neuropeptide release, reducing inflammation and pain-signal transmission.
Sources for this answer
- Maxalt Melt 10 mg Oral LyophilisatesOrganon Pharma (UK) Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 10Document updated
Sources checked